SCHEMBL713480

SCHEMBL713480

CCCCC(O)C(OC)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SPHK1 Q9NYA1 2/20 0.41
CYP2D6 P10635 2/20 0.39
CA2 P00918 2/20 0.39
GMNN O75496 1/20 0.39
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
BLM P54132 1/20 0.39
KDM4E B2RXH2 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
MAPT P10636 1/20 0.39
CETP P11597 1/20 0.39
HTT P42858 1/20 0.39
UBE2N P61088 1/20 0.39
CA1 P00915 1/20 0.39
ALDH1A1 P00352 1/20 0.36
ABCB1 P08183 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6850921 0.91 SPHK1 (0.54) SPHK1CYP2D6GMNNLMNAPOLB
SCHEMBL29457699 0.84 LMNA (0.42) SPHK1LMNA
SCHEMBL29457698 0.84 LMNA (0.42) SPHK1LMNA
SCHEMBL26633394 0.79 SPHK1 (0.47) SPHK1CYP2D6GMNNLMNAPOLB
SCHEMBL26633398 0.79 SPHK1 (0.47) SPHK1CYP2D6GMNNLMNAPOLB
SCHEMBL1234977 0.78 SPHK1 (0.52) SPHK1CYP2D6CA2GMNNLMNA
SCHEMBL7708644 0.78 SPHK1 (0.52) SPHK1CYP2D6CA2GMNNLMNA
SCHEMBL30575899 0.78 SPHK1 (0.52) SPHK1CYP2D6CA2GMNNLMNA
SCHEMBL600713 0.78 SPHK1 (0.52) SPHK1CYP2D6CA2GMNNLMNA
SCHEMBL27881377 0.78 SPHK1 (0.52) SPHK1CYP2D6CA2GMNNLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9908970-B2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method NEKTAR THERAPEUTICS (US) 2018-03-06 US disclosed
US-20170121459-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS 2017-05-04 US disclosed
US-9579392-B2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method NEKTAR THERAPEUTICS (US) 2017-02-28 US disclosed
US-20160144046-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS 2016-05-26 US disclosed
US-9228053-B2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method NEKTAR THERAPEUTICS (US) 2016-01-05 US disclosed
US-20130280783-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD NEKTAR THERAPEUTICS 2013-10-24 US disclosed
EP-2170804-B1 Method of producing 2-phenoxyacetals and the corresponding 2-phenoxy-carbaldehydes therefrom SALTIGO GMBH (DE) 2013-08-28 EP disclosed
EP-2170804-B1 Method of producing 2-phenoxyacetals and the corresponding 2-phenoxy-carbaldehydes therefrom SALTIGO GMBH (DE) 2013-08-28 EP disclosed
US-8492503-B2 Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method NEKTAR THERAPEUTICS (US) 2013-07-23 US disclosed
US-8143455-B2 Process for preparing 2-hydroxyacetals and the corresponding 2-hydroxyalkanals SALTIGO GMBH (US) 2012-03-27 US disclosed
US-20110230618-A1 Polymeric Alpha-Hydroxy Aldehyde and Ketone Reagents and Conjugation Method NEKTAR THERAPEUTICS (US) 2011-09-22 US disclosed
US-20100286449-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM SALTIGO GMBH (DE) 2010-11-11 US disclosed
US-20100286449-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM SALTIGO GMBH (DE) 2010-11-11 US disclosed
US-20100286449-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM SALTIGO GMBH (DE) 2010-11-11 US disclosed
US-20100280276-A1 PROCESS FOR PREPARING 2-HYDROXYACETALS AND THE CORRESPONDING 2-HYDROXYALKANALS SALTIGO GMBH (DE) 2010-11-04 US disclosed
US-20100280276-A1 PROCESS FOR PREPARING 2-HYDROXYACETALS AND THE CORRESPONDING 2-HYDROXYALKANALS SALTIGO GMBH (DE) 2010-11-04 US disclosed
EP-2170804-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM Saltigo GmbH (DE) 2010-04-07 EP disclosed
WO-2009000651-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM SALTIGO GMBH (DE) 2008-12-31 WO disclosed
WO-2009000651-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM SALTIGO GMBH (DE) 2008-12-31 WO disclosed
WO-2009000649-A1 PROCESS FOR PREPARING 2-HYDROXYACETALS AND THE CORRESPONDING 2-HYDROXYALKANALS SALTIGO GMBH (DE) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280276-A1 PROCESS FOR PREPARING 2-HYDROXYACETALS AND THE CORRESPONDING 2-HYDROXYALKANALS HAO2, HAO1, AKR1C3 SPHK1 2668/4885CYP2D6 17/4885CA2 370/4885
US-20100286449-A1 METHOD OF PRODUCING 2-PHENOXYACETALS AND THE CORRESPONDING 2-PHENOXY-CARBALDEHYDES THEREFROM CYP2B6, CYP2A6, UGT1A6 SPHK1 3744/4885CYP2D6 4/4885CA2 754/4885
US-20160144046-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD ASPH, ALDH1A1, ADH1C SPHK1 1269/4885CYP2D6 1275/4885CA2 2753/4885
US-20130280783-A1 POLYMERIC ALPHA-HYDROXY ALDEHYDE AND KETONE REAGENTS AND CONJUGATION METHOD ASPH, ALDH1A1, ADH1C SPHK1 1269/4885CYP2D6 1275/4885CA2 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.